Mostrar el registro sencillo del ítem

dc.contributor.authorAdeyelu, Tolulope
dc.contributor.authorBordin, Nicola
dc.contributor.authorWaman, Vaishali P.
dc.contributor.authorSadlej, Marta
dc.contributor.authorSillitoe, Ian
dc.contributor.authorMoya-García, Aurelio Ángel 
dc.contributor.authorOrengo, Christine A.
dc.date.accessioned2023-03-06T17:46:27Z
dc.date.available2023-03-06T17:46:27Z
dc.date.issued2023-02-02
dc.identifier.citationAdeyelu T, Bordin N, Waman VP, Sadlej M, Sillitoe I, Moya-Garcia AA, Orengo CA. KinFams: De-Novo Classification of Protein Kinases Using CATH Functional Units. Biomolecules. 2023; 13(2):277. https://doi.org/10.3390/biom13020277es_ES
dc.identifier.urihttps://hdl.handle.net/10630/26094
dc.description.abstractProtein kinases are important targets for treating human disorders, and they are the second most targeted families after G-protein coupled receptors. Several resources provide classification of kinases into evolutionary families (based on sequence homology); however, very few systematically classify functional families (FunFams) comprising evolutionary relatives that share similar functional properties. We have developed the FunFam-MARC (Multidomain ARchitecture-based Clustering) protocol, which uses multi-domain architectures of protein kinases and specificity-determining residues for functional family classification. FunFam-MARC predicts 2210 kinase functional families (KinFams), which have increased functional coherence, in terms of EC annotations, compared to the widely used KinBase classification. Our protocol provides a comprehensive classification for kinase sequences from >10,000 organisms. We associate human KinFams with diseases and drugs and identify 28 druggable human KinFams, i.e., enriched in clinically approved drugs. Since relatives in the same druggable KinFam tend to be structurally conserved, including the drug-binding site, these KinFams may be valuable for shortlisting therapeutic targets. Information on the human KinFams and associated 3D structures from AlphaFold2 are provided via our CATH FTP website and Zenodo. This gives the domain structure representative of each KinFam together with information on any drug compounds available. For 32% of the KinFams, we provide information on highly conserved residue sites that may be associated with specificity.es_ES
dc.description.sponsorshipAdeyelu T, Bordin N, Waman VP, Sadlej M, Sillitoe I, Moya-Garcia AA, Orengo CA. KinFams: De-Novo Classification of Protein Kinases Using CATH Functional Units. Biomolecules. 2023; 13(2):277. https://doi.org/10.3390/biom13020277es_ES
dc.language.isoenges_ES
dc.publisherIOAP-MDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBIOQUIMÍCA MOLECULARes_ES
dc.subjectBIOLOGÍA MOLECULARes_ES
dc.subject.otherProtein kinaseses_ES
dc.subject.otherFunctional familieses_ES
dc.subject.otherKinFamses_ES
dc.subject.otherKinBase classificationes_ES
dc.titleKinFams: De-Novo Classification of Protein Kinases Using CATH Functional Unitses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.centroFacultad de Cienciases_ES
dc.identifier.doihttps://doi.org/10.3390/biom13020277
dc.rights.ccAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional